Breast and Ovarian Cancer, HBOC, Hereditary

Genetic test Export to PDF
Full name:
Breast and Ovarian Cancer, HBOC, Hereditary
Test type:
Clinical
Test specialty:
Molecular Genetics
Test purpose:
Mutation confirmation,
Post-natal Diagnosis,
Pre-implantation genetic diagnosis,
Predictive and Pre-symptomatic diagnosis,
Therapeutic Management
Specimen:
Peripheral (whole) blood on EDTA,
DNA
Method category:
Method technique:
Laboratory:
RIZIV code:
EQA:
  • 2016 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2018 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2020 Hereditary Breast and Ovarian Cancer (panel testing) EMQN
Accreditation (ISO 15189):
2021-09-11 / 2026-09-10
Turnaround time (maximum):
4 months (please inform the lab for urgent cases)
Document(s):
Created:
29 Jul 2019 - 08:47
Changed:
20 Sep 2023 - 13:12